New “Danaher Beacon,” first in the European Union, aims to accelerate translation, scalability, and reliability across cell and gene therapy ...
The last available hemophilia gene therapy is temporarily unavailable, according to CSL Behring. | The company is working ...
Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...
Morning Overview on MSN
Common gene variant may raise Alzheimer’s risk; researchers eye gene therapy
A genetic variant carried by at least one-fifth of the population may do far more than raise the odds of developing Alzheimer ...
You were recruited to Memorial Sloan Kettering in the late 1990s to set up one of the first clinical-grade gene transfer facilities in the country. Can you tell us that backstory? This was a field ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results